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Background: Nuclear factor kappa B (NF-κB) is a key transcription factor that plays a crucial role in host survival
during infection by pathogens. Therefore, it has been a priority of many pathogens to manipulate the cellular NF-κB
activity in order to create a favorable environment for their survival inside the host.
Results: We observed that heterologous expression of the open reading frame 2 (ORF2) protein in human
hepatoma cells led to stabilization of the cellular I kappa B alpha (IκBα) pool, with a concomitant reduction in the
nuclear localization of the p65 subunit of NF-κB and inhibition of NF-κB activity. Although basal or TPA induced
phosphorylation of IκBα was not altered, its ubiquitination was markedly reduced in ORF2 expressing cells. Further
analysis revealed that ORF2 protein could directly associate with the F-box protein, beta transducin repeat
containing protein (βTRCP) and ORF2 over expression resulted in reduced association of IκBα with the SKP1 and
CUL1 components of the SCFβTRCP complex. Chromatin immunoprecipitation (ChIP) assay of the proximal promoter
regions of MHC-I heavy chain and IL-8 genes using p65 antibody and LPS stimulated ORF2 expressing cell extract
revealed decreased association of p65 with the above regions, indicating that ORF2 inhibited p65 binding at
endogenous promoters.
Conclusions: In this report we suggest a mechanism by which ORF2 protein of HEV may inhibit host cell NF-κB
activity during the course of a viral infection.Background
Nuclear factor kappa B (NF-κB) is a crucial transcription
factor regulating multiple cellular pathways leading to sur-
vival or death of the cell depending on the stimulus. In un-
stimulated cells, the NF-κB dimers (p50/p65 heterodimer
or p50/p50 homodimer) are retained in the cytoplasm in
an inactive form as a consequence of their association with
members of another family of proteins called I kappa B
(IκB). Upon stimulation by activators like tumor necrosis
factor alpha (TNF-α), interleukin 1 (IL-1), CD40L, lipopo-
lysaccharides (LPS) etc., signaling cascades involving acti-
vation of various protein kinases are initiated that result in
the recruitment and activation of the IκB kinases (IKKs)* Correspondence: sunilklal@icgeb.res.in
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reproduction in any medium, provided the orwhich phosphorylate IκBα, leading to its degradation by
the 26S proteasome complex. The degradation of IκBα
exposes the p50/p65 nuclear localization sequence and
allows NF-κB dimers to translocate to the nucleus, bind to
κB motifs in the promoters regions of many genes, and
regulate their transcription [1].
In many cases, infection by extra-cellular pathogens has
been shown to alter NF-κB activity in order to facilitate
the survival of pathogens or host. As part of the host
defense mechanism against invading pathogens, NF-κB
activation is required for resistance to a variety of viral,
bacterial, and parasitic infections [1]. However, many
viruses such as HIV, exploit this property to their benefit
by driving their gene expression through κB response ele-
ments located in their promoters [2]. On the contrary,
many pathogens such as African swine fever virus, HIV-1
and cowpox virus [3-5] have developed strategies tod. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Figure 1 Heterologous expression of ORF2 protein inhibits
NF-κB activity. (A) Huh7 cells were cotransfected in duplicate with
NF-κB CAT reporter and pSGI vector or pSGI-ORF2 expression
plasmid. 48 hour post transfection, cells were treated with
100 ng/ml TPA for 30 minutes and CAT activity was assayed. Spot
intensity was quantified using NIH Image program and percentage
CAT activity was calculated assuming the highest value as 100%.
Graph represents mean± SEM of 3 independent sets of experiments.
(B) Huh7 cells were cotransfected in duplicate with NF-κB CAT
reporter, IKKβ expression plasmid and pSGI vector or pSGI ORF2
expression plasmid. 48 hour post transfection, CAT activity was
assayed. Graph represents mean± SEM of 3 independent sets of
experiments.
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activity by these pathogens has been shown to be import-
ant for pathogenesis.
Hepatitis E virus (HEV) is a positive strand RNA virus
which codes for three known open reading frames (ORFs)
[6]. ORF1 codes for non structural proteins, essential for
viral replication; ORF2 codes for the major capsid protein
of HEV, called ORF2 protein; and ORF3 codes for a
phosphoprotein which may play a key role in manipulat-
ing various host-cell processes during viral infection, and
may have a role in cell survival and propagation of the
virus [7,8]. Although HEV infection is generally self-limit-
ing, it induces fulminant hepatic failure, which results in a
very high mortality rate in pregnant women. A recent
study done by Prusty and coworkers has demonstrated
that NF-κB activity is suppressed in the PBMC and liver
biopsy samples of pregnant fulminant hepatic failure
patients [9]. However, the mechanism underlying this
phenomenon remains unknown.
In the present study, we report the ability of the ORF2
protein to inhibit the cellular NF-κB activity. In human
hepatoma cells, ORF2 protein could directly associate
with the F-box protein βTRCP and heterologous expres-
sion of the ORF2 protein led to reduced recruitment of
SKP1 and CUL1 subunits to the SCFβTRCP ubiquitina-
tion complex, resulting in decreased ubiquitination and
degradation of the IκBα protein. This, in turn, led to
reduced nuclear localization and subsequent DNA bind-
ing of the p65 protein, which is the major subunit of the
NF-κB trans-activation complex. Analysis of two NF-κB
target genes further confirmed the above observation.
The possible significance of this phenomenon in enhan-
cing survival of HEV infected hepatocytes is discussed.
Results
Heterologous expression of the ORF2 protein inhibits
NF-κB activity
In order to test whether ORF2 or ORF3 protein of HEV
inhibit cellular NF-κB activity, a reporter vector with IL-2
receptor promoter region, which contains NF-κB element,
cloned upstream of the chloramphenicol acetyl transferase
coding sequence (NF-κB CAT; [10] was used. This vector
was inducible by NF-κB activating agents like TPA or
IL-1β. Huh7 cells were transiently transfected with the
NF-κB CAT vector along with either ORF2 or ORF3 ex-
pression plasmids. Assay of chloramphenicol acetyl
transferase (CAT) activity using these cell extracts
revealed that ORF2 protein inhibited the NF-κB CAT
activity (Figure 1A). However, no inhibition was observed
by ORF3 expression (Figure 1A). In order to investigate
whether ORF2 mediated inhibition of NF-κB activity was
an artifact of the experimental system, cells were treated
for 30 minutes with Phorbol 12-myristate 13-acetate
(TPA), a known inducer of NF-κB activity [11], ortransfected with an expression construct of IκB kinase β,
which is the catalytic subunit of the IKK complex that acts
as a constitutively active inducer of NF-κB activity [12].
TPA treatment increased NF-κB activity of mock trans-
fected cells by approximately 4 folds whereas ORF2
expressing cells did not show any significant increase in
NF-κB activity (Figure 1A). Similarly, co-expression of
ORF2 in IKKβ transfected cells resulted in downregulation
of NF-κB activity in comparison to cells transfected with
only IKKβ (Figure 1B). These results clearly suggest that
HEV ORF2 inhibits NF-κB activity.
Further, we examined the turnover of IκBα in IΚKβ
and ORF2 co-expressing cells since IκBα is the major in-
hibitor of NF-κB activity in unstimulated cells. By per-
forming a pulse chase assay, using [35S]-cys/met labeling
mix, the half-life of IκBα in IKKβ expressing cells was
found to be approximately 90 minutes, whereas in cells
expressing both IKKβ and ORF2, approximately 15% of
pSGI      +           - + -
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Figure 2 ORF2 protein increases the half life of cellular IκBα protein. (A) Huh7 cells were cotransfected with IKKβ and pSGI or pSGI ORF2
expression plasmids and pulse chased, as described in methods. Total IκBα was immunoprecipitated and samples were resolved on 12% SDS-
PAGE and bands were detected by autoradiography. Band intensities were quantified using NIH Image program and graph was plotted assuming
protein level at zero time to be 100%. In the graph, thin dotted line represents IKKβ transfected sample and solid line represents ORF2 and IKKβ
cotransfected samples. Similar results have been obtained in 3 independent experiments. (B) Cytoplasmic (lane 1, 2) and nuclear (lane 3, 4)
fractions of pSGI or pSGI ORF2 transfected cells were immunoprecipitated and subsequently western blotted with anti-p65 antibody (upper
panel). A fraction of lysates were western blotted with calnexin and phospho c-Jun antibodies. Graph represents quantitation of p65 band
intensities from the above image. Similar results have been obtained in 2 independent experiments. (C) Huh7 cells were transfected with
expression plasmids: Lane 1, ORF2; lane 2, pSGI vector; lane 4 and 6, IKKβ; lane 3 and 5, ORF2 and IKKβ. Cell lysates were immunoblotted with
phospho-IκBα, (ser 32), IκBα and calnexin antibodies. MG-132 was added 3 hours prior to cells harvesting. Graph shows quantitative
representation of calnexin value normalized band intensities of phospho- IκBα and total IκBα from the above image. Similar results have been
obtained in 3 independent experiments. (D) pSGI vector or pSGI ORF2 (lane 2 and 3) transfected cell lysates were immunoblotted with phospho
IKKα/β (ser 180/181) and calnexin antibodies. 2 μg & 4 μg denotes the respective amount of DNA transfectedh.
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90 minutes (Figure 2A). Notably, the levels of IκBα at
the end of the labeling period (0 minute chase) in IKKβ
alone expressing cells were less than that in IKKβ and
ORF2 coexpressing cells, indicating that IκBα is a very
labile protein in IKKβ expressing cells. The graph repre-
sents quantitative measurement of band intensities of
IκBα at the indicated time points assuming the bandintensity at the onset of the chase as 100%. To further
confirm whether IκBα stabilization actually blocked nu-
clear translocation of NF-κB in ORF2 expressing cells,
nuclear and cytoplasmic fractions were separated in
mock and ORF2 transfected cells and equal amounts of
samples were immunoprecipitated with anti-p65 anti-
body. As seen in Figure 2B, ORF2 transfected cells were
found to accumulate more p65 protein in the
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(Figure 2B, lane 2 and 4; see the densitometric estima-
tion of band intensities in the graph below). As
expected, mock transfected cells were found to contain
more p65 protein in the nuclear fraction (Figure 2B, lane
1 and 3). This is attributed to the fact that basal NF-κB
activity is higher in Huh7 cells [13]. In order to check
the purity of fractions obtained in nuclear and cytoplas-
mic fractions and as loading controls, equal amounts of
both fractions from each sample were immunoblotted
with anti-calnexin and anti-phospho c-Jun antibodies.
In order to check whether the phosphorylation of IκBα
was altered in ORF2 expressing cells, the level of phos-
phorylated IκBα (ser32) was measured in ORF2 expressing
cells. ORF2 expression marginally increased the levels of
phospho IκBα (Figure 2C, upper panel, lane 1 and 2; see
the densitometric estimation of band intensities in the
graph below) as well as the level of total IκBα (middle
panel, lane 1 and 2). In IKKβ and ORF2 co-expressing
cells, the level of total as well as phosphorylated IκBα was
significantly higher as compared to only IKKβ expressing
cells (Figure 2C, lane 3 and 4). In order to check that the
decreased band intensity in IKKβ expressing cells was due
to accelerated degradation of IκBα, one set of cells were
also treated with the proteasome inhibitor MG-132 for
2 hours, resulting in equal IκBα protein levels in both the
samples (Figure 2C, lane 5 and 6). Aliquots of the sample
were immunoblotted with anti-calnexin antibody to check
equal loading. Thus, it appears that ORF2 expression pre-
vents the degradation of IκBα. The fact that ORF2 did not
interfere with phosphorylation of IκBα by the IKK complex
was further confirmed by checking the activity of the IKK
complex. ORF2 expressing cell lysate was immunoblotted
for phospho IKKα/β (ser180/181) levels. As expected,
ORF2 expression (2 or 4 μg plasmid DNA transfection) did
not modulate the levels of pIKK α/β (Figure 2D).
ORF2 protein interferes with IκBα ubiquitination
Proteasomal degradation of IκBα is preceded by its ubiqui-
tination, which occurs by the association of phosphory-
lated IκBα with the SCFβTRCP complex [14]. In order to
check whether ORF2 inhibits IκBα ubiquitination, we
checked the level of ubiquitinated IκBα in ORF2 expres-
sing cells. Mock or ORF2 transfected cells were treated
with MG-132 for 2 hours, IκBα was immunoprecipitated,
followed by immunblotting with anti-ubiquitin antibody.
Protein level of ubiquitinated IκBα was significantly
decreased in full-length ORF2 expressing cells as com-
pared to control cells (Figure 3A top panel, lane 1 and 2).
A similar effect (lane 3) was observed following expression
of a mutant ORF2 protein (Δ35) with ER signal sequence
deleted which consequently constitutively localizes to the
cytoplasm [15]. Aliquots of the immunoprecipitated lysate
were immunoblotted with IκBα antibody to confirm itspresence (Figure 3A, middle panel). A parallel set of sam-
ples were labeled with [35S]-cys/met promix, immunopre-
cipitated with anti-ORF2 antibody and autoradiographed
to check the expression of full-length and Δ35 ORF2 pro-
tein (Figure 3A, bottom panel).
Subsequently, we checked whether ORF2 interfered with
the assembly of IκBα ubiquitination machinery. Expres-
sion of ORF2 protein inhibited the association of IκBα
with SKP1 (Figure 3B, top panel) and CUL1 (Figure 3B,
2nd panel) in a dose-dependent manner (compare lane 1
with lanes 2 and 3). Aliquots of the sample were immuno-
blotted with anti-IκBα antibody to check the levels of IκBα
(3rd panel). A parallel set of samples were labeled with
[35S]-cys/met and immunoprecipitated with anti-ORF2
antibody to check the expression of ORF2 (Figure 3B, 4th
panel). To further check whether the ORF2 expression in
these cells inhibited the association of IκBα with the F-box
protein βTRCP, ORF2 and myc tagged βTRCP co-
expressing cells were labeled with [35S]-cys/met and ali-
quots of the lysate were immunoprecipitated with anti-
myc antibody and immunoblotted using anti-IκBα anti-
body. ORF2 expression led to the inhibition of IκBα asso-
ciation with full-length βTRCP when compared to control
cells (Figure 3C, lane 3 and 2, respectively). However,
IκBα association with an F-box deleted mutant βTRCP
(ΔF-βTRCP) remains unaffected despite the presence of
ORF2 (Figure 3C, lane 5). The same blot was stripped and
reprobed with anti-myc antibody to check the expression
of full-length and ΔF-βTRCP (Figure 3C, lower panel, lane
1–5). Lane 1 shows the protein level of total IκBα. 50% of
the sample has been loaded in lane 1 in comparison to
other samples. The other half of the blot was autoradio-
graphed to check the expression of the ORF2 protein
(Figure 3C, lower panel, lane 6–8).
Since the presence of ORF2 could inhibit IκBα associ-
ation with full-length βTRCP but not with ΔF-βTRCP,
we postulated that the ORF2 protein either interacts
with IκBα and sequesters it away from βTRCP or inter-
acts with other subunits of the SCF complex thereby
modulating βTRCP binding to IκBα. Alternatively, it
binds to βTRCP itself and blocks the formation of the
SCF complex. We thus checked the association of ORF2
with the above components. No interaction was detected
between ORF2 and IκBα (Figure 3C, lane 6) as judged
by coimmunoprecipitation assay. The possibility that
βTRCP over-expression might be promoting ORF2 asso-
ciation with IκBα was ruled out by testing ORF2 and
IκBα association in full-length or ΔF- βTRCP over-
expressing cells (Figure 3D, lane 7 and 8). Lane 1 shows
the level of IκBα in control cells. Subsequently, we
checked whether ORF2 interacts with SKP1 and CUL1.
The ORF2 protein did not associate with either SKP1 or
CUL1 (Figure 3D, lane 1 and 2) under conditions, where
IKBα associated with these proteins (lane 3).
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Figure 3 ORF2 protein interferes with IκBα ubiquitination. (A) Huh7 cells transfected with pSGI vector, ORF2 (full-length) and Δ35 ORF2
expression constructs were labeled metabolically with [35S]-cys/met promix and treated with MG-132 for 2 hours prior to lysis. Lysates were
immunoprecipitated with anti-IκBα antibody and immunoblotted with anti-ubiquitin antibody (upper panel). Same blot was stripped and
reprobed with IκBα antibody (middle panel). An aliquot of the lysate was immunoprecipitated with anti-ORF2 antibody and radioactive bands
were detected by autoradiography (lower panel). (B) Huh7 cells transfected with pSGI (lane 1) or ORF2 (increasing DNA amounts, lane 2 and 3)
expression plasmids were metabolically labeled with [35S]-cys/met promix. Lysates were immunoprecipitated with IκBα antibody and
immunoblotted with SKP1, CUL1 and IκBα antibodies. An aliquot of lysate was immunoprecipitated with anti-ORF2 antibody and radioactive
bands were detected by autoradiography. Graph represents percent band intensities of Skp1, Cul1 and IκBα (from lanes 1–3) levels, considering
the intensity of pSGI transfected band in lane 1 as 100%. Similar results have been obtained in 3 independent experiments. (C) Huh7 cells
expressing the indicated protein were immunoprecipitated with the respective antibodies and immunoblotted anti-IκBα antibody (upper panel).
Same blot was stripped, cut into halves and immunoblotted with anti-myc (lower pane, lane 1–5) or anti-ORF2 (lane 6–8) antibodies. In lane 1,
50% of the sample has been loaded in comparison to other lanes. Graph represents percent IκBα band intensity, considering the intensity of IκBα
band in lane 2 as 100%. Similar results have been obtained in 3 independent experiments. (D) pSGI vector (lane 3) or pSGI ORF2 (lane 1 and 2)
transfected cells were labeled with [35S]-cys/met promix and lysates were immunoprecipitated with anti-IκBα antibody, pre-immune serum (PS) or
anti-ORF2 antibodies, respectively; subsequently, samples were immunoblotted with SKP1 and CUL1 antibodies. Same blot was air dried and
exposed to X-ray film to check for ORF2 expression by autoradiography.
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βTRCP
Coimmunoprecipitation assay of cell lysate expressing
both ORF2 and myc tagged full-length βTRCP revealed
that ORF2 could efficiently associate with the latter
(Figure 4A, upper panel, lane 2). Exposure of the same
blot to X-ray film revealed the band specific to ORF2 in
βTRCP and ORF2 cotransfected cells (Figure 4A, lower
panel, lane 2). 3rd lane in upper panel shows the expres-
sion of the βTRCP protein, as judged by immunoprecipi-
tation using anti-myc antibody. Specificity of the aboveinteraction was further verified by checking for associ-
ation of ORF2 with another F-box protein, SKP2. We
were unable to detect any interaction between ORF2
and SKP2 as judged by coimmunoprecipitation assay
(Figure 4B, top panel). In order to ensure that SKP2 was
indeed functional in these experiments, the same blot
was stripped and reprobed with anti-myc antibody. En-
dogenous SKP2 was able to coprecipitate endogenous as
well as overexpressed c-myc protein (Figure 4B, middle
panel) and similarly IP using myc antibody revealed its
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Figure 4 ORF2 protein associates with βTRCP protein. (A) Huh7 cells were transfected with pSGI, ORF2 and myc tagged βTRCP expression
constructs in indicated combinations and labeled with [35S]-cys/met promix. Lysates were immunoprecipitated with anti-ORF2 (lane 1 and 2) or
anti-Myc (lane 3) antibody and immunoblotted with anti-Myc antibodies. Immunoblot presented in upper panel was air dried and exposed to
X-ray film to check for ORF2 expression (lower panel). (B) Huh7 cells transfected with pSGI vector or ORF2 or c-Myc expression constructs were
labeled with [35S]-cys/met promix, immunoprecipitated with the indicated antibodies and immunoblotted with anti-SKP2 or anti-Myc antibodies.
Myc blot was air dried and exposed to X-ray film to check for ORF2 expression (3rd panel). (C) Lysates from mock (lane 2), ORF2 (lane 3 and 6),
Δ35 ORF2 (lane 4) and KDEL ORF2 (lane 5) transfected Huh7 cells, were immunoprecipitated using anti-ORF2 antibody (lane 2–5) or pre-immune
serum (PS, lane 6) and incubated along with in vitro translated [35S]-cys/met labeled full-length βTRCP protein (lane 2–6). Bound βTRCP protein
band was visualized by autoradiography. Lane 1 represents total βTRCP protein used in each sample. For negative control, ORF3 expressing cells
were immunoprecipitated with anti-ORF3 antibody and processed as above (lane 7).
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radiogram of ORF2 expression. These experiments
proved that ORF2 specifically interacts with the F-box
protein βTRCP. Direct interaction between ORF2 and
βTRCP was further confirmed using an in vitro pull-
down assay. Full-length ORF2 as well as KDEL ORF2
(ORF2 protein containing “KDEL” amino acids at its
C-terminal end, which allows it to be retained in the endo-
plasmic reticulum instead of getting transported through
the golgi) and Δ35 ORF2 mutant were able to pull-down
βTRCP (Figure 4C, lane 3, 4, 5). As negative controls,
ORF2 transfected sample was immunoprecipitated withpre-immune serum (Figure 4C, lane 6) or mock translated
lysate was incubated with ORF2 protein bound to beads
(Figure 4C, lane 2) or, the ORF3 protein was incubated
with βTRCP protein (Figure 4C, lane 7).
The ORF2 protein downregulates the expression of NF-κB
targets
NF-κB is known to regulate the transcription of a large
number of genes during different cellular conditions.
One of the most critical events for initiation of immune
response against viral antigens is the presentation of
viral peptide epitopes over the infected cell surface,
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viral antigens are presented through their association
with the major histocompatibility complex-I (MHC-I).
As MHC-I heavy chain is a known target of NF-κB, we
checked expression levels of the MHC-I heavy chain in
ORF2 expressing cells stimulated with bacterial lipopoly-
sacharides (LPS). EGFP (Figure 5A, lane 1), full-length
ORF2 (Figure 5A, lane 2) or Δ35-ORF2 (Figure 5A, lane 3)
transfected cells were treated with LPS for 45 minutes
and total cell lysate was immunoprecipitated and im-
munoblotted with anti-MHC-I heavy chain antibody
(Figure 5A, upper panel). Protein level of MHC-I heavy
chain was decreased in both full-length and Δ35-ORF2
expressing cells in comparison to EGFP expressing
cells. An aliquot of the lysate was immunoblotted with
anti-calnexin antibody to ensure equal loading of the
sample (lower panel).
Further, we checked NF-κB recruitment to the MHC I
heavy chain promoter in LPS stimulated ORF2 expressing
cells by chromatin immunoprecipitation (ChIP) assay.
Immunoprecipitation was conducted using an antibody
specific for the p65 subunit of the NF-κB complex. EGFP
expression did not alter p65 recruitment to MHC-I heavy
chain promoter. However, full-length or Δ35-ORF2 expres-
sion decreased p65 recruitment to the MHC-I heavy chain
promoter. 10% of the total lysate used for one immuonpre-
cipitation reaction was used as input in each sample
(Figure 5B, upper panel). We also checked p65 recruitment
to interleukin 8 (IL-8) proximal promoter region, which
showed a similar pattern as observed for the MHC-I heavy
chain promoter (Figure 5B, lower panel). As a control to
check whether the observed phenomenon was specific for
NF-κB, aliquots of the LPS treated lysate were immunopre-
cipitated with anti-SP1 antibody (specific for SP1 transcrip-
tion factor, which also binds to MHC-I heavy chain
promoter) and purified ChIP DNA was PCR amplified
using MHC-I heavy chain promoter specific primer. As
expected, SP1 recruitment to the MHC-I heavy chain
promoter was not altered in ORF2 expressing cells
(Figure 5C). These experiments confirmed that ORF2 ex-
pression specifically prevents p65 NF-κB association with
its cognate response element present on natural promoters.
Next, the effect of ORF2 protein on the expression of
two TPA inducible cytokines- IL-6 and IL-8 was mea-
sured by performing real time quantitative RT-PCR of
these cytokine transcripts in ORF2 expressing Huh7
cells, which were treated with TPA for 6 hours prior to
RNA isolation. As expected, IL-6 and IL-8 transcript
level was decreased in
ORF2 expressing TPA treated cells in comparison to
mock transfcetd TPA treated cells (Figure 5D). These
experiments indicates that ORF2 protein, by virtue of its
ability to inhibit NF-κB activity, suppress TPA induced
IL-6 and IL-8 RNA synthesis.Discussion
The ORF2 protein of HEV has traditionally been believed
to associate with genomic RNA, multimerize and form the
viral capsid. No other function of ORF2 protein has yet
been reported. In this article, we present evidence which
suggest that the ORF2 protein may be playing an import-
ant regulatory role during the viral life cycle. The fact that
the observed phenomenon was not an artifact of the ex-
perimental setup was evident from multiple experiments.
First, ORF2 was capable of directly interacting with the
F-box protein βTRCP, both in vitro and in vivo. Second,
Δ35 ORF2 mutant that is unable to translocate to the
endoplasmic reticulum (ER), was also capable of inhibiting
NF-κB activity, thus ruling out the possibility of ER stress
induced artifact. Third, ORF3 protein of HEV was unable
to elicit such a function in parallel experiments.
HEV infection results in an acute, self-limiting and ic-
teric disease that is prevalent in much of the developing
world. Although self-limiting infection occurs in adults
with mortality rate ~1–2%, a high 10–20% mortality rate
is observed during pregnancy [6]. Hence it is important to
understand the molecular mechanism by which HEV
completes its life cycle inside the host. A recent study
done by Prusty and coworkers revealed that NF-κB activity
is inhibited in the PBMC and liver of fulminant hepatic
failure patients [9]. Our findings that the ORF2 protein
has the ability to inhibit NF-κB activity in human hepa-
toma cells provide a possible molecular explanation to
their observation.
The NF-κB inhibitory activity of the ORF2 protein may
be mediated by its ability to directly associate with the
F-box protein βTRCP and inhibit the assembly of the IκBα
ubiquitination complex. βTRCP is a cytoplasmic protein.
Hence it is worth speculating that the ORF2 βTRCP inter-
action would occur in the cytoplasm. Although ORF2 is
an N-linked glycoprotein, which is cotranslationally trans-
located to the endoplasmic reticulum, recent studies per-
formed in our laboratory have demonstrated that a fraction
of ORF2 protein exploits the ER retro-translocation ma-
chinery to get access to the cytoplasm, where it is detected
as a non-glycosylated protein. Importantly, in contrast to
other retrotranslocated substrates, retrotranslocated ORF2
protein is not immediately degraded by the 26S prote-
asome complex present in the cytoplasm [16]. Thus, cyto-
plasm localized deglycosylated ORF2 protein may be able
to associate with βTRCP. Indeed, experiments done using
Δ35 ORF2 protein suggest that non-glycosylated, cyto-
plasm localized ORF2 protein is capable of associating with
βTRCP and inhibiting NF-κB activity. Further studies need
to be undertaken to verify the exact mechanism.
Expression of MHC class I heavy chain, which is
known to be a transcriptional target of NF-κB, was
down-regulated in LPS treated ORF2 expressing cells
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Figure 5 ORF2 protein inhibits the expression of MHC-I heavy chain. (A) EGFP, ORF2 or Δ35 ORF2 expressing cells were treated with LPS for
45 minutes after 48 hours of transfection. Lysates were immunoprecipitated and immunoblotted with anti-MHC-I heavy chain antibody (upper
panel). An aliquot of the lysate was immunoblotted with anti-calnexin antibody (lower panel). (B) To test p65 NF-κB binding to the MHC-I heavy
chain and IL-8 promoters ChIP assay was performed. Huh7 Cells were transfected with EGFP, ORF2 or Δ35 ORF2 expression plasmids and treated
with LPS for 45 minutes prior to harvesting. PCR was performed using primers flanking the proximal promoter region of MHC-I heavy chain and
IL-8 genes. Lane 7 shows ChIP from EGFP expressing cells immunoprecipitated with rabbit pre-immune serum. Lane 8 shows ChIP from mock
immuonprecipitation (without cell lysate) using p65 antibody. 10% of the initial amount of chromatin used for one immuonprecipitation assay
was used as input in each PCR. (C) SP1 binding to the MHC-I heavy chain ptomoter was again assayed by ChIP. Huh7 Cells were transfected with
EGFP or full-length ORF2 expression plasmids and treated with LPS for 45 minutes prior to harvesting. PCR for MHC-I promoter regions was
performed using primers mentioned above. Lane 5 shows ChIP from EGFP expressing cells immunoprecipitated with rabbit pre-immune serum.
Lane 6 shows ChIP from mock immunoprecipitation using SP1 antibody. 10% of the initial amount of chromatin used for one
immuonprecipitation assay was used as input in each PCR. (D) Quantitative RT-PCR analysis of IL-6 and IL-8 RNA level in Huh7 cells, treated as
indicated. Values were normalized with respect to that of HPRT and represented as mean± SEM.
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tivation. In an infected cell, by default, pathogenic anti-
gens are processed by the proteasome and presented by
the MHC class I molecules so that the former can be
recognized by cytolytic T cells. This helps in pathogen
clearance at an early stage of infection. Thus, it is benefi-
cial for any pathogen to escape this step. In fact, down-
regulation of MHC class I both at transcriptional and
post-translational level is observed in many pathogenic
infections [17-19]. Since NF-κB is one of the major tran-
scription factors induced during pathogen infection that
enhances gene expression of many chemokines and class
I molecules in the infected cell, inhibition of the NF-κB
activity by pathogen encoded proteins will ensure eva-
sion of host immune response at an early stage; thus
providing the pathogen a time window to establish suc-
cessful infection.
Conclusions
Owing to its central role in regulating multiple cell sig-
naling pathways, modulation of NFKB activity has been
an attractive target of many viral factors in order to
allow them to exploit the host cell signaling machinery
to their benefit. We have identified the ability of the
ORF2 protein of the HEV to inhibit host cell NFKB ac-
tivity. However, whether such an event is recapitulated
during the natural course of HEV infection and whether
it is crucial for the virus induced pathogenic effects, can
be answered only by performing similar experiments
using a model organism infected with the wild type
virus. Nevertheless, the present study confirms the
NFKB inhibitory property of the HEV ORF2 protein and
provides some evidence suggesting a plausible mechan-
ism underlying this event.
Methods
Plasmids and reagents
Cloning of ORF2 and Δ35 ORF2 in pSGI has been
described earlier [15]. Flag tagged IKKβ [12], IL-2 recep-
tor α promoter containing NF-κB response element
cloned upstream of the chloramphenicol acetyl ransfer-
ase (CAT) coding sequence (NF-κB CAT) [10], Wild-
type, ΔF βTRCP cDNA in pCDNA3.1 [20] and pSGI
c-myc [21] constructs were gifts from Drs. Rene Bernards,
Ranjan Sen, Richard Benarous and Vijay Kumar, respect-
ively. All DNA constructs used for mammalian cell
transfection were purified by cesium chloride gradient
centrifugation [22].
All antibodies were purchased from Santa Cruz Bio-
technology Inc. (California, USA); TPA and MG-132
were purchased from Calbiochem Chemicals (California,
USA). LPS was purchased from Sigma-Aldrich (USA).
[35S]-cysteine/methionine labeling mix was obtained
from New England Nuclear (Massachusetts, USA).Cell culture and transfection
Human Hepatoma (Huh7) cells were maintained in
DMEM supplemented with penicillin, streptomycin and
10% fetal bovine serum. Cells were transfected with
Lipofectin/Lipofectamine 2000 reagent (Invitrogen Corp.,
California, USA) as per manufacturer’s instructions. For
negative control conditions, cells were transfected with
their respective empty vectors. In all transfections, total
DNA amount was equalized by adding pSGI vector.
Metabolic labeling, immunoprecipitation and
immunoblotting
Radiolabeling of cells with [35S]-cys/met promix, immu-
noprecipitation and immunoblotting was done as
described earlier [8]. Data obtained is representative of
at least 3 independent sets of experiments conducted.
Results were quantified using the NIH Image V: 1.32
program, normalized values calculated and graphs plot-
ted wherever indicated. All the inhibitors were added
during starvation period and maintained throughout the
labeling period.
Effective concentrations of different compounds used:
TPA 100 ng/ml, MG-132 50 μM, LPS 10 μg/ml.
Pulse chase assay
Cells were pulse-labeled for 20 minutes with 250 μCi of
[35S]-cys/met labeling mix and chased in complete
medium for the indicate time periods, followed by
immunoprecipitation, as described before [23].
Chloramphenicol acetyl transferase (CAT) assay
Forty eight hours post-transfection, cells were harvested
in phosphate buffer saline and CAT assay was conducted
as described elsewhere [21].
In vitro protein expression
βTRCP protein was expressed in-vitro using pCDNA-
βTRCP expression construct in a coupled transcription-
translation reaction (TNT kit, Promega Corp., Wisconsin,
USA) following manufacturers protocol.
Nuclear fractionation
Nuclear fractionation was performed as described earlier
[23].
Chromatin immunoprecipitation (ChIP) assay
Cells cultured in 60 mm dish were transfected in triplicate
with respective plasmids. Control samples were transfected
with EGFP expression plasmid (pSGI-EGFP). Forty-eight
hours post-transfection, cells were fixed in 1% formalde-
hyde and ChIP assay was performed as described elsewhere
[24]. Forward and reverse primer sequences for amplifica-
tion of MHC-I heavy chain promoter were 50 CAGGGAGT
CCAGTTCAGGGA 30 and 50 TGAGTCCGGGTGGGTGC
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were 50 GGGCCATCAGTTGCAAA TC 30 and 50 TTCCT
TCCGGTGGTTTCTTC 30, respectively.
RNA isolation and real time quantitative RT-PCR analysis
RNA was isolated from Huh7 cells using Trizol reagent
(Invitrogen) following manufacturers protocol, followed
by reverse transcription and real time quantitative RT-
PCR analysis as described [25].
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